Lucia AFib App outperforms standard of care in prospective pilot study
San Diego, September 21, 2023 — Lucia Health Guidelines, a company applying machine learning at the point of care in the treatment of atrial fibrillation (AFib), today announced that its first prospective study was nominated Top 5 abstracts at 2023 HRX AbstracX.
The abstract, “Point of Care AI Driven ER2EP Referrals for Non-Valvular Atrial Fibrillation Patients in the Emergency Department,” looked at the feasibility of using a point-of-care mobile application to improve guideline-consistent treatment of AFib in the emergency department, direct referral pathway to electrophysiology (EP) outpatient, and outcomes. Lucia’s machine learning algorithm allows non-cardiology clinicians to detect AFib on an electrocardiogram (ECG), initiate guideline-recommended treatment, and refer patients to practitioners that can manage their AFib longer-term.
Results found that the Lucia AFib App offered guideline-consistent treatment recommendations in 100% of the 22 patients in the intervention group, while 77.3% of those patients received direct EP referrals. A total of 12 of the 22 (54%) intervention patients received an AFib procedure versus zero (0%) for the control group. Lastly, while not statistically significant, the intervention group saw 4% readmission versus 11% for the control group.
About Lucia Health Guidelines
Lucia Health Guidelines is a medical technology company creating clinical decision support tools for the point of care. Lucia is committed to using technology to improve guideline-based care in an effort to close gaps and improve health equity. Trained by leading cardiac electrophysiologists, Lucia’s machine learning algorithm allows any clinician to confidently confirm atrial fibrillation on electrocardiogram in order to initiate care.
Contact
Mathew Rothway
mathew@luciaguidelines.com
